Carl Zeiss Meditec Returns to Significant Revenue Growth in Second Quarter 2020/21
Carl Zeiss Meditec AG has achieved revenue of EUR 767.4 million in the first half of fiscal year 2020/21. This corresponds to a revenue development of +7.3% vs. the past year (after adjustment for currency effects: +10.5%). In the second quarter of FY 2020/21, revenue amounted to EUR 398.5 million – a growth rate of +15.4% (after adjustment for currency effects: +18.8%).
Earnings before interest and taxes (EBIT) amounted to EUR 162.7 million in the first half of FY 2020/21. EBIT margin (EBIT / revenue) was 21.2%. In the second quarter of FY 2020/21, EBIT amounted to EUR 89.3 million. EBIT margin was 22.4%.
Full results for the first half 2020/21 will be published on May 10, 2021.
During the further course of FY 2020/21, the company expects an ongoing normalization of business development. Revenue is expected to reach around EUR 1.6 billion in FY 2020/21. EBIT margin for FY 2020/21 is projected to reach a level of approximately 20%.
Click HERE for the full press release.